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Background: Success of biofilm dwelling bacteria in causing persistent and chronic infections is attributed to their
resistance towards antibiotics and immune defences. Free iron is critical for the growth of biofilm associated
bacteria. Therefore in the present study, the effect of limiting iron levels by addition of divalent Co[II] ions in
combination with a bacteriophage was used for preventing/disrupting Klebsiella pneumoniae biofilms.
Results: A significantly higher reduction (p < 0.005) in bacterial numbers in the younger as well as older biofilms
treated with Co[II] and depolymerase producing phage in combination was observed in comparison to when either
of the agents was used alone. The role of phage borne depolymerase was confirmed, as an insignificant eradication
of biofilm by non-depolymerase producing bacteriophage in combination with cobalt ions was observed. The
results of viable count were further confirmed by visual examination of biofilms.
Conclusion: From the study it can be concluded, that iron antagonizing molecules and bacteriophages can be
used as adjunct therapy for preventing biofilm development.
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Biofilms are cell-cell or solid surface-attached assem-
blages of microbes that are entrenched in a hydrated,
self-produced matrix [1]. Bacteria growing in biofilms
exhibit increased resistance to antimicrobials and host
immune response compared to their freeliving, plank-
tonic counterparts due to several reasons like restricted
penetration of antimicrobials into a biofilm, decreased
growth rate, and expression of possible resistance genes
[2]. Klebsiella pneumoniae is an important biofilm for-
ming organism responsible for a wide range of infections
placing it among the eight most important nosocomial
pathogens [3]. The threat of antibiotic resistance and their
inability in breaking the biofilm structure has increased
the likelihood that novel strategies for preventing or
delaying the biofilm growth mode are urgently needed [4].
Bacteriophages infect bacteria, hijack their machinery,
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reproduction in any medium, provided the orlysis. They offer various advantages over antibiotics as
antibiofilm agents because of their specific, non-toxic,
self replicating and self limiting nature [5,6]. Phage
borne depolymerases degrade biofilm exopolysaccharide
matrix that acts as a barrier for antimicrobials, infect the
organisms and cause extensive biofilm disruption [7].
Since phages are rapidly removed from circulation once
injected/ingested, are unable to penetrate the older
biofilms which contain large number of metabolically
inactive cells [8] thus it can be said that either phages or
antibiotics when used alone do not stand a chance
especially against biofilm associated bacterial infections.
Therefore, treating biofilms with combinations of
chemically distinct antimicrobials might be an effective
strategy to kill some of these different cell types.
Iron is an essential factor in bacterial growth participa-
ting in oxygen and electron transport processes, essential
for biofilm formation in bacteria [9,10] where it regulates
surface motility, promotes biofilm formation by stabilizing
the polysaccharide matrix [11] and is considered critical
for transition from planktonic to sessile existence. Thus,
reducing iron availability has been proposed as a potentialal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Pseudomonas aeruginosa, Escherichia coli etc. [12-15]. In
light of this emerging perspective, we undertook the
present study to explore the possibility of using an iron
antagonizing molecule and a bacteriophage alone as well
as in combination to inhibit biofilm formation by K.
pneumoniae B5055.
Methods
Bacterial strain, phages and growth conditions
K. pneumoniae B5055 (O1:K2) obtained originally from
Dr. Mathia Trautmann, Department of Medical Micro-
biology and Hygiene, University of Ulm, Germany;
KPO1K2 and NDP, depolymerase and non-depolymerase
producing phages against K. pneumoniae B5055, previ-
ously characterized in our laboratory [16-18] were used
in the present study. As reported earlier by Verma et al.
[16] phage KPO1K2 possesses icosahedral head with
pentagonal nature with apex to apex head diameter of
about 39 nm. It has a genome of 42 kbps, a short
noncontractile tail (10 nm) and a T7 like structural protein
pattern suggesting its inclusion into family Podoviridae
with a designation of T7-like lytic bacteriophage.
The titre of the bacteriophage preparation was
estimated by the soft agar overlay method [19] and was
expressed as plaque forming units/ml (pfu/ml). Nutrient
broth was used routinely for bacterial culture; bacterial
dilutions were made in sterile 0.85% sodium chloride
(NaCl) whereas dilutions of phage were made in sterile
Phosphate Buffer Saline (PBS). Biofilm experiments in
96 well microtiter plates as well as on cover slips were
conducted in M9 minimal medium [composition/100 ml:
disodium hydrogen phosphate (Na2HPO4)–65 mg, potas-
sium dihydrogen phosphate (KH2PO4)–150 mg, sodium
chloride (NaCl)-25 mg, ammonium chloride (NH4Cl)–
50 mg, magnesium sulphate (MgSO4)–12 mg, calcium
chloride (CaCl2)–0.5 mg, glucose −200 mg] and iron
(FeCl3) was supplemented as indicated. The divalent metal
ion containing salt, CoSO4 was used as the iron antago-
nizing molecule at a concentration of 500 μM.
Biofilm growth on microtiter plates
K. pneumoniae biofilms were grown in 96-well micro-
titer plate according to method described by Bedi et al.
[20]. Briefly, 100 μl of minimal M9 medium and 100 μl
of bacterial culture (OD600 = 0.3) equivalent to 10
8 CFU/
ml of K. pneumoniae were added to the wells of microti-
ter plate and incubated at 37°C overnight. In each test,
control wells containing sterile minimal media were
included that acted as plate sterility control. After every
24 h, planktonic bacteria were removed and a set of two
wells (corresponding to each day) were washed thor-
oughly 3 times with 0.85% NaCl. Adherent biofilms were
scraped from 2 wells, suspended in 0.85% NaCl andvortexed for 3 min using Remi Cyclomixer (Remi Instru-
ments & Appliances Ltd, Bombay, India). Microbial load
of biofilm was enumerated by viable cell counting. In
rest of the wells, spent medium was replaced with fresh
sterile M9 media and plate was reincubated at 37°C
overnight. This procedure was repeated until 7th day of
experiment.
Biofilm growth in iron supplemented minimal media
Different wells of 96-well microtiter plate were inocu-
lated with 100 μl of K. pneumoniae culture (OD600 = 0.3)
equivalent to a bacterial cell density of 108 CFU/ml and
100 μl of M9 media supplemented with different con-
centrations of FeCl3 (0, 10 μM, 100 μM, 1000 μM). After
overnight incubation at 37°C contents of all wells were
removed and from two set of wells containing 0/10 μM/
100 μM/1000 μM FeCl3 supplemented minimal media
unadhered bacteria were washed off, biofilms were
scraped from 8 wells, cells were enumerated by plating
on nutrient agar plates. In rest of the wells, spent
medium was replaced with fresh sterile M9 media and
plate was reincubated at 37°C overnight. This procedure
was repeated until 7th day of experiment.
Biofilm growth in iron supplemented minimal media with
cobalt addition
To determine the efficacy of Cobalt sulphate (CoSO4) in
inhibiting the biofilm growth, 100 μl of K. pneumoniae
was inoculated in different wells of microtiter plate
containing 100 μl of minimal media supplemented with
10 μM FeCl3 or 500 μM of Cobalt sulphate (CoSO4)
alone or in combination. After overnight incubation at
37°C contents of all wells were removed and from two
set of control wells and wells with 10 μM FeCl3/500 μM
CoSO4/both, supplemented minimal media (8 samples)
unadhered bacteria were removed and viable counts
were determined. Reduction in log values of bacterial
count was noted in comparison to untreated control. In
rest of the wells, spent medium was replaced with fresh
media and plate was reincubated at 37°C overnight. This
procedure was repeated until 7th day of experiment.
Bacteriophage treatment of biofilm grown in minimal
media supplemented with cobalt (CoSO4) and iron (FeCl3)
salts
To determine the efficacy of bacteriophage alone as well
as in combination with the iron anatagonizing molecule
in treating the biofilms of K. pneumoniae B5055, 100 μl
of bacterial culture was inoculated in different wells of
microtiter plate containing 100 μl of minimal media
supplemented with 10 μM FeCl3 and/or 500 μM of Co-
balt sulphate (CoSO4) and incubated at 37°C overnight.
Unadhered bacteria were removed from two set of wells
supplemented with 10 μM FeCl3 and 10 μM FeCl3+ 500 μM
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exposed to bacteriophage (KPO1K2/NDP) at multiplicity
of infection [m.o.i: ratio of infectious agent (e.g. phage or
virus) to infection target (e.g. bacterial cell)] of 1 for 3 h
followed by washing with 0.85% NaCl and enumeration of
viable cells from 8 wells. A set of two wells containing
biofilm grown in unsupplemented, iron supplemented
minimal media alone and with the addition of CoSO4
served as controls and were also processed as mentioned
previously on each day. In rest of the wells, spent medium
was replaced with fresh media and plate was re-incubated
at 37°C overnight. This procedure was repeated until 7th
day of experiment.
Development of biofilm on glass coverslip
To determine the effectivness of treatment with various
combinations qualitatively, biofilms were grown on glass
coverslips (18 mm × 18 mm; 0.08–0.12 mm; Corning
Glass, USA) at air–liquid interface by the Tipbox batch
culture method of Hughes et al. [7] as standardized in
our laboratory by Verma et al. [18]. Tip-box mounted
coverslips and minimal M9 media supplemented with
10 μM FeCl3 with or without 500 μM CoSO4 were steril-
ized separately. 100 μl bacterial culture (108 CFU/ ml)
was added to the media which was then poured into the
tip box. The whole set-up was incubated at 37°C. Spent
growth medium in the culture boxes was replaced every
24 h. On 3rd and 7th day 16 coverslips (4 corresponding
to each group) were removed, rinsed thoroughly with
sterile 0.85% NaCl and 8 were incubated with bacterio-
phage (MOI = 1) for 3 hours. After treatment, biofilm
laden coverslip was washed with sterile sodium phos-
phate buffer (pH 7.2), stained for 15 min in dark with
the components of LIVE/DEAD BacLight Bacterial
Viability Kit (Invitrogen), washed with 0.85% NaCl and
observed under oil immersion 100× objective, with a
B2A filter set fitted in a fluorescent microscope (Nikon).
The images were captured using an image acquisition
system by Nikon. The untreated cover-slips were also
processed in a similar way as treated ones. 8 cover slips
(2 for each group) were processed for ascertaining the
viable cell count of the treated as well as untreated
biofilm.
Statistical analysis
All experiments were performed in duplicate and
repeated at least three times on different days. The
bacterial count was log10 transformed as described by
Anderl et al. [21]. On different days of biofilm forma-
tion, all the data from a particular treatment and from
particular time points were grouped separately and the
log reductions in comparison to untreated biofilm at the
respective time points were calculated. The effect of
different treatments on biofilm eradication was evaluatedby the Student’s t-test and P < 0.05 was considered
significant. Data were analyzed using Excel software.
Results
Establishment of biofilms on microtiter plates in iron
supplemented media
K. pneumoniae biofilms was established in minimal (M9)
media and bacterial count was enumerated on various
days. Initially, bacterial count for the young immature
2nd day biofilms was 6.7 ± 0.08 Log10 CFU/ml followed
by a peak on day 4 (7.12 ± 0.04 Log10 CFU/ml) and a
further decline resulting in a bacterial count of 6.6 ± 0.10
Log10 CFU/ml on 7
th day for the older mature biofilm.
The effect of supplementation with different concen-
trations of FeCl3 in minimal media was studied on the
biofilm growth. Addition of 10 μM FeCl3 enhanced the
growth as a significant increase (p < 0.05) in the bacterial
count was observed 2nd day onwards (Figure 1) in
comparison with non-iron supplemented control wells.
This increase was consistent throughout the incubation
period. On the contrary, wells supplemented with 100
and 1000 μM of FeCl3 showed reduction 4
th day onwards
with respect to control and 10 μM FeCl3 containing wells.
Antimicrobial treatment of biofilms grown on microtiter
plates
The effect of addition of iron antagonizing molecule i.e.
CoSO4 on K. pneumoniae B5055 biofilms grown in
minimal media supplemented with 10 μM FeCl3 was stu-
died and it was observed that although supplementation
with 10 μM FeCl3 resulted in significant enhancement of
biofilm growth but addition of 500 μM chelator alone
exerted minimal inhibitory effect on biofilm growth in
comparison to control wells containing no iron or chela-
tor. When a combination of 10 μM FeCl3 and 500 μM
CoSO4 was added together, there was a significant
decrease (p < 0.05) of ~2 logs in the younger biofilms till
3rd day but the reduction decreased to ~ 1 log from 5th
day onwards for the older biofilms in comparison to the
control wells containing no FeCl3 and CoSO4 (Figure 2).
To determine the efficacy of iron antagonizing molecule
and depolymerase producing phage (KPO1K2) alone or in
combination in eradicating the biofilms of K. pneumoniae
B5055 grown in M9 media supplemented with 10 μM
FeCl3, phage was added at a MOI of 1 to wells containing
10 μM FeCl3 and/or 10 μM FeCl3 along with 500 μM
CoSO4. The results presented in Figure 3 show that
addition of 500 μM CoSO4 or KPO1K2 to the wells
containing 10 μM FeCl3 resulted in a significant decrease
(p < 0.05) of ~2 log for the younger biofilms (1–3 day old)
in comparison to control wells supplemented with 10 μM
FeCl3 alone. There was no significant reduction (p > 0.05)
in bacterial count of the older biofilms (4–7 day old).
Addition of 500 μM CoSO4 as well as phage in 10 μM
Figure 1 Kinetics of biofilm formation by K. pneumoniae B5055 grown in minimal media (M9) with or without supplementation of
FeCl3. *p < 0.05 (10 μM FeCl3 vs control group).
Figure 2 Kinetics of biofilm formation by K. pneumoniae B5055 grown in minimal media (M9) containing cobalt salt (CoSO4) or FeCl3
alone and in combination. *p < 0.05 (10 μM FeCl3 + 500 μM CoSO4 vs 10 μM FeCl3), ¶ p < 0.05 (10 μM FeCl3 + 500 μM CoSO4 vs 500 μM CoSO4).
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Figure 3 Kinetics of biofilm formation by K. pneumoniae B5055 grown in minimal media (M9) supplemented with 10 μM FeCl3 and
treated with 500 μM cobalt salt (CoSO4) and bacteriophage (KPO1K2)/ (NDP) alone as well as in combination. *p < 0.05 [(10 μM
FeCl3 +500 μM CoSO4 + Ø(KPO1K2) vs 10 μM FeCl3/10 μM FeCl3+ 500 μM CoSO4/10 μM FeCl3+ Ø(KPO1K2)], **p < 0.005 [(10 μM FeCl3 +500 μM
CoSO4 + Ø(KPO1K2) vs 10 μM FeCl3/10 μM FeCl3+ 500 μM CoSO4/10 μM FeCl3+ Ø(KPO1K2)],
#p < 0.05 [(10 μM FeCl3 + Ø(KPO1K2) vs 10 μM FeCl3],
$p < 0.05[(10 μM FeCl3 +500 μM CoSO4) vs 10 μM FeCl3], !p > 0.05[(10 μM FeCl3 +500 μM CoSO4 + Ø(NDP) vs 10 μM FeCl3+ 500 μM CoSO4].
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of 1st and 2nd day biofilms (p < 0.005). A significant reduc-
tion (p < 0.05) of ~2 log was observed in 3rd and 4th day
biofilms in comparison to biofilms treated with cobalt or
phage individually. 5th day onwards a consistent reduction
of ~0.5-1 log10 CFU/ml was observed in wells with cobalt
and/or phage alone as well as in combination when
compared with control biofilms containing 10 μM FeCl3
supplemented media. These results indicated that CoSO4
and phage when added in combination although resulted
in complete eradication of younger biofilm but had a very
little inhibitory effect on the older biofilms of K. pneu-
moniae B5055 [Figure 3].
To determine the efficacy of non-depolymerase produ-
cing phage (NDP) in eradicating the biofilms of K.
pneumoniae B5055, it was added alone and along
with 500 μM of CoSO4 in minimal media supplemented
with 10 μM FeCl3. Results indicated that treatment with
phage alone resulted in a reduction of ~1 log on younger
biofilms as shown in Figure 3. However, the phage was
totally ineffective for older biofilms (4th day onwards).
On the other hand, treatment with 500 μM cobalt alone
could significantly inhibit biofilm formation till 4th day
(p < 0.05) but later on became ineffective, for older
biofilms. Treatment with non-depolymerase producing
phage and chelator in combination had no additive
effect on biofilm eradication in comparison to biofilmstreated with depolymerase producing phage and CoSO4
in combination (Figure 3).
Growth and treatment of Klebsiella pneumoniae B5055
biofilm formed on coverslip
Besides studies carried out in microtiter wells, biofilm of
K. pneumoniae B5055 was established in iron and iron +
cobalt supplemented minimal media on coverslips and
were exposed to phage KPO1K2 (MOI = 1) for 24 hours.
A higher surface area i.e. 324 mm2 of the cover slip
allowed enhanced biofilm formation by approximately ~1
log on the cover slip in comparison to the microtiter plate
(surface area = 32 mm2). Estimation of bacterial numbers
in untreated biofilms at the air–liquid interface showed an
increase, with a peak on 5th day (9.09 ± 0.15 Log10 CFU/ml)
of incubation, after which the biofilm bacterial counts
decreased progressively (Figure 4). In biofilm treated with
both phage and cobalt salt a mean log reduction of ~5
and ~ 2 logs was observed in comparison to the groups
treated with phage or iron antagonizing molecule alone.
The growth and treatment efficacy of biofilm formed at
the air–liquid interface was ~1-2 logs better in compa-
rison to biofilms grown in microtiter plates therefore for
further experiments biofilm were grown on glass cover-
slips at the air–liquid interface. On 3rd and 7th day, the
bacterial viability in the treated/untreated biofilms was
assessed by fluorescent microscopy.
Figure 4 Kinetics of biofilm formation (on cover slips) by K. pneumoniae B5055 grown in minimal media (M9) supplemented with
10 μM FeCl3 and treated with 500 μM cobalt salt (CoSO4) and bacteriophage (KPO1K2) alone as well as in combination. **p < 0.005
[(10 μM FeCl3 +500 μM CoSO4 + Ø(KPO1K2) vs 10 μM FeCl3/10 μM FeCl3+ 500 μM CoSO4/10 μM FeCl3+ Ø(KPO1K2)], *p < 0.05 [(10 μM
FeCl3 +500 μM CoSO4 + Ø(KPO1K2) vs 10 μM FeCl3+ 500 μM CoSO4],
#p < 0.005 [(10 μM FeCl3 +500 μM CoSO4 + Ø(KPO1K2) vs 10 μM FeCl3/
10 μM FeCl3+ Ø(KPO1K2)].
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The LIVE/DEAD BacLight Bacterial Viability Kit has a
mixture of SYTO® 9 green-flourescence nucleic acid
stain (for intact live bacteria) and propidium iodide red
flourescence nucleic acid stain (for membrane damaged
or killed bacteria). Two types of cells were seen, green
cells represented the intact or viable cells, red stained
cells represented damaged or killed bacterial cells after
treatment while yellow regions showed the presence of
both red and green coloured cells. As shown in [Figure
5(a)] a 3rd day biofilm consisting of sparsely populated
green coloured rods formed in the iron supplemented
media in comparison to 7th day old thicker and densely
populated green coloured biofilm [Figure 5(a´)]. On the
other hand, biofilm grown in additional cobalt supple-
mented media showed a lesser confluent growth of
green colored cells along with some yellow and red cells
on 3rd day [Figure 5(b)] as well as on 7th day [Figure 5(b´)]
in comparison to biofilms grown in iron supplemented
media. 3rd day biofilm grown in iron supplemented media
treated with phage alone consisted of sparsely populated
green cells with many red coloured rods [Figure 5(c)] in
comparison to 7th day biofilm grown in iron supple-
mented media and treated with phage alone where
although a denser biofilm was formed but compared to
3rd day biofilm, it consisted of maximum number of red
colored cells in comparison to the green cells [Figure 5(c´)].
When biofilms grown in iron supplemented media were
treated with cobalt as well as phage in combination, a negli-
gible amount of biofilm formation consisting of mostly ofred and yellow regions was seen on day 3 [Figure 5(d)]
as well as on day 7 [Figure 5(d´)] when compared with
3rd and 7th day biofilms treated with cobalt as shown in
[Figure 5(b) and Figure 5(b´)] respectively or phage
alone [Figure 5(c) and Figure 5(c´)].
Discussion
Biofilms are recalcitrant to antibiotics as their higher con-
centrations are needed to eradicate bacterial cells in this
mode of growth. Attempts have been made in the past to
evolve alternate strategies to destroy biofilms. Since
bacteria, both in planktonic and biofilm mode require iron
for their growth [14] hence, iron chelating agents have
been reported to inhibit biofilm growth. Hancock et al.
[15] have reported that since Zn (II) and Co (II) have a
higher than iron affinity for the master controller protein
of iron uptake i.e. ‘Fur’ thus they reduce biofilm formation
by infectious E. coli. In this study, a significant reduction
(p < 0.05) was observed in the growth of younger biofilms
(1–3 day old) when 500 μM CoSO4 and 10 μM FeCl3
supplemented media was used. This might be because of
the elevated levels of metals which could interfere with
normal iron regulation by shutdown of Fur-controlled
iron uptake systems like enterobactin, ferric dicitrate,
aerobactin as well as additional downstream effects on
putative adhesion factors involved in biofilm establish-
ment thereby resulting in deleterious effect on biofilm
formation [2,22] as well as pathogenicity of the organism.
No previous reports are available involving the use of
phage and iron antagonizing molecules in combination
Figure 5 K. pneumoniae B5055 biofilm developed on coverslip (a/a´) 3/7 day biofilm grown in 10 μM FeCl3 supplemented media (b/b´)
3/7 day biofilm grown in 10 μM FeCl3 + 500 μM cobalt salt supplemented media (c/c´) 3/7 day biofilm grown in 10 μM FeCl3
supplemented media followed by treatment with phage KPO1K2 (d/d´) 3/7 day biofilm grown in 10 μM FeCl3 + 500 μM cobalt salt
supplemented media followed by treatment with phage KPO1K2.
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depolymerase producing phage (KPO1K2) in eradicating
the biofilms of K. pneumoniae B5055 grown in minimal
media supplemented with 500 μM CoSO4 and iron. A
complete eradication of the younger biofilms (upto 2 day
old) given combination treatment was observed. This
was possibly due to the degradation of exopolysaccha-
ride matrix encompassing the biofilm structure by the
phage encoded depolymerase [7,17] which facilitated the
process of bacterial growth inhibition by phage as well
as CoSO4. These results suggests that prior addition of
CoSO4 and later treatment with depolymerase producingphage is quite effective in degrading biofilms. Further-
more, when biofilms of different ages were treated with
non-depolymerase producing phage (NDP) alone as well
as in combination with CoSO4, a less reduction in over-
all bacterial load was observed in comparison to biofilms
treated with depolymerase producing phage and CoSO4
together. These findings suggest that this might be due
to the degradation of exopolysaccharide matrix of
biofilm by depolymerase enzyme that facilitated the
diffusion of cobalt ions.
Qualitative analysis of viability of biofilms treated with
phage in the presence and absence of cobalt ions was
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Bacterial Viability Kit. Appearance of maximum number
of dead cells and formation of thin biofilms indicated
the effectiveness of the combined treatment with CoSO4
and bacteriophage. Previous works by O’May et al.
[14] and Reid et al. [23] have also reported inhibition
in P. aeruginosa biofilm formation by iron chelator
and tobramycin when observed by staining with BacLight
Bacterial Viability staining kit.
Conclusion
Since, a rise in antimicrobial resistance has made the
chase for development of newer antimicrobials especially
against biofilm related infections necessary and also
because of the various advantages bacteriophages offer
over antibiotic treatment they can be used alone as well
as in combination with the other therapies such as iron
chelators/antagonizing molecules. This strategy although
needs further exploration particularly for in vivo applica-
tions, but can be exploited for coating of devices with
iron chelators to reduce biofilm formation and subse-
quent treatment of established biofilms with phages as
adjuncts to the already available antibiotics.
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